Summary
Despite considerable improvements in the variety and effectiveness of therapeutic agents in recent years, advanced metastatic cancers remain largely incurable. Therefore, the development of novel therapeutic agents is needed. Chimeric Antigen Receptor-modified T cells (CAR-T)...
More information & hyperlinks
| Web resources: | https://www.clinicbarcelona.org/idibaps |
Search
Organisations
- Not specified